{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:40:55Z","timestamp":1738042855224,"version":"3.33.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Prostate cancer is the second most common type of cancer in male worldwide. Stromal-epithelial interaction is thought to have a major impact on cancer development and progression. Previous studies have shown that interaction via soluble factors lead to a reduction in the expression of xCT and AL122023.1 in the prostate carcinoma cell line LNCaP after seven days of co-culture with primary stromal p21 cells. In this study, we validated the repression of <jats:italic>xCT<\/jats:italic> and <jats:italic>AL122023<\/jats:italic>.<jats:italic>1<\/jats:italic> at RNA level using quantitative real-time PCR and at protein level by Western Blotting. Furthermore, xCT is known to be a putative target for miRNAs miR-26a, miR-30d and miR-30e, which in turn potentially interact with AL122023.1. The lncRNA-miRNA-interaction was verified by luciferase reporter assays. However, miR-26a\/-30d\/-30e did not inhibit xCT expression at protein level. Nevertheless, indirect inhibitory effect of AL122023.1 on the xCT expression could be shown. Moreover, immunostaining revealed precise xCT expression in neuroendocrine cells, ranging from fetal, healthy juvenile, and adult prostate tissue to benign prostatic hyperplasia and finally advanced prostate cancer. This study explores the relevance and function of xCT and AL122023.1 in the prostate and exposes xCT as a potential marker or therapeutic target in high-risk prostate cancer.<\/jats:p>","DOI":"10.1371\/journal.pone.0318213","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T18:36:45Z","timestamp":1738003005000},"page":"e0318213","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a\/30d\/30e axis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5383-6619","authenticated-orcid":true,"given":"Elena D.","family":"Wilhelm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5950-0742","authenticated-orcid":true,"given":"Jaroslaw T.","family":"Dankert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Wieseh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Wach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Spahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Kruithof-de Julio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3313-2475","authenticated-orcid":true,"given":"Gunther","family":"Wennemuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"pone.0318213.ref001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"H. Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"pone.0318213.ref002","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1038\/s41598-019-40820-2","article-title":"An analysis of benign human prostate offers insights into the mechanism of apocrine secretion and the origin of prostasomes","volume":"9","author":"N. J. Fullwood","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0318213.ref003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00296871","article-title":"Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate","volume":"22","author":"M. A. Noordzij","year":"1995","journal-title":"Urol Res"},{"key":"pone.0318213.ref004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00268938","article-title":"Do neuroendocrine cells in human prostate cancer express androgen receptor?","volume":"100","author":"J. L. Krijnen","year":"1993","journal-title":"Histochemistry"},{"key":"pone.0318213.ref005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01606893","article-title":"Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate","volume":"423","author":"H. Bonkhoff","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"pone.0318213.ref006","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1074\/jbc.M116.755082","article-title":"Neuroendocrine Cells of the Prostate Derive from the Neural Crest","volume":"292","author":"J. Szczyrba","year":"2017","journal-title":"J Biol Chem"},{"key":"pone.0318213.ref007","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1242\/dev.148270","article-title":"Prostate organogenesis: tissue induction, hormonal regulation and cell type specification","volume":"144","author":"R. Toivanen","year":"2017","journal-title":"Development"},{"key":"pone.0318213.ref008","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1212585","article-title":"Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells","volume":"13","author":"E. D. Czyrnik","year":"2023","journal-title":"Front. Oncol"},{"key":"pone.0318213.ref009","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The Role of Non-coding RNAs in Oncology","volume":"179","author":"F. J. Slack","year":"2019","journal-title":"Cell"},{"key":"pone.0318213.ref010","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","author":"J. S. Mattick","year":"2006","journal-title":"Hum Mol Genet"},{"key":"pone.0318213.ref011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"D. P. Bartel","year":"2009","journal-title":"Cell"},{"key":"pone.0318213.ref012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"B. P. Lewis","year":"2005","journal-title":"Cell"},{"key":"pone.0318213.ref013","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"S. Lin","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"pone.0318213.ref014","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41419-021-03854-x","article-title":"Role of noncoding RNA in drug resistance of prostate cancer","volume":"12","author":"L. Ding","year":"2021","journal-title":"Cell Death Dis"},{"key":"pone.0318213.ref015","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","article-title":"Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins","volume":"274","author":"H. Sato","year":"1999","journal-title":"J Biol Chem"},{"key":"pone.0318213.ref016","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","article-title":"Exchange of cystine and glutamate across plasma membrane of human fibroblasts","volume":"261","author":"S. Bannai","year":"1986","journal-title":"J Biol Chem"},{"key":"pone.0318213.ref017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"S. C. Lu","year":"2009","journal-title":"Mol Aspects Med"},{"key":"pone.0318213.ref018","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"W. S. Yang","year":"2014","journal-title":"Cell"},{"key":"pone.0318213.ref019","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ijc.24715","article-title":"Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence","volume":"127","author":"M. Spahn","year":"2010","journal-title":"Int J Cancer"},{"key":"pone.0318213.ref020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eururo.2014.01.020","article-title":"Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study","volume":"67","author":"S. Joniau","year":"2015","journal-title":"Eur Urol"},{"key":"pone.0318213.ref021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.juro.2012.02.2572","article-title":"Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease","volume":"188","author":"M. Spahn","year":"2012","journal-title":"J Urol"},{"key":"pone.0318213.ref022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/rna.4.2.4640","article-title":"Identification of human microRNA targets from isolated argonaute protein complexes","volume":"4","author":"M. Beitzinger","year":"2007","journal-title":"RNA Biol"},{"key":"pone.0318213.ref023","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Z. Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pone.0318213.ref024","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1038\/onc.2017.146","article-title":"ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner","volume":"36","author":"D. Chen","year":"2017","journal-title":"Oncogene"},{"key":"pone.0318213.ref025","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/cne.23889","article-title":"Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed","volume":"524","author":"J. Van Liefferinge","year":"2016","journal-title":"J Comp Neurol"},{"key":"pone.0318213.ref026","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010064","article-title":"RNA Sequencing of Collecting Duct Renal Cell Carcinoma Suggests an Interaction between miRNA and Target Genes and a Predominance of Deregulated Solute Carrier Genes","volume":"12","author":"S. Wach","year":"2019","journal-title":"Cancers (Basel)"},{"key":"pone.0318213.ref027","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.febslet.2011.04.018","article-title":"MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11","volume":"585","author":"X. X. Liu","year":"2011","journal-title":"FEBS Lett"},{"key":"pone.0318213.ref028","doi-asserted-by":"crossref","first-page":"e00178","DOI":"10.14309\/ctg.0000000000000178","article-title":"Role of the Outer Inflammatory Protein A\/Cystine-Glutamate Transporter Pathway in Gastric Mucosal Injury Induced by Helicobacter pylori","volume":"11","author":"J. Du","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"pone.0318213.ref029","doi-asserted-by":"crossref","first-page":"101402","DOI":"10.1016\/j.redox.2019.101402","article-title":"miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia","volume":"29","author":"H. Zhang","year":"2020","journal-title":"Redox Biol"},{"key":"pone.0318213.ref030","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180677","article-title":"TUG1 promotes prostate cancer progression by acting as a ceRNA of miR-26a","volume":"38","author":"B. Yang","year":"2018","journal-title":"Biosci Rep"},{"key":"pone.0318213.ref031","doi-asserted-by":"crossref","first-page":"37423","DOI":"10.1074\/jbc.M506439200","article-title":"Redox imbalance in cystine\/glutamate transporter-deficient mice","volume":"280","author":"H. Sato","year":"2005","journal-title":"J Biol Chem"},{"key":"pone.0318213.ref032","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nm.4232","article-title":"Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth","volume":"23","author":"S. L. Cramer","year":"2017","journal-title":"Nat Med"},{"key":"pone.0318213.ref033","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7150\/ijbs.53126","article-title":"Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8)","volume":"17","author":"Y. Huang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"pone.0318213.ref034","doi-asserted-by":"crossref","first-page":"105305","DOI":"10.1016\/j.phrs.2020.105305","article-title":"Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer","volume":"164","author":"X. Zhou","year":"2021","journal-title":"Pharmacol Res"},{"key":"pone.0318213.ref035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pros.20508","article-title":"Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy","volume":"67","author":"D. W. Doxsee","year":"2007","journal-title":"Prostate"},{"key":"pone.0318213.ref036","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13402-019-00474-8","article-title":"The Xc(-) inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism","volume":"43","author":"Z. Zheng","year":"2020","journal-title":"Cell Oncol (Dordr)"},{"key":"pone.0318213.ref037","first-page":"6417","article-title":"Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors","volume":"34","author":"E. Lachaier","year":"2014","journal-title":"Anticancer Res"},{"key":"pone.0318213.ref038","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer","volume":"81","author":"A. Ghoochani","year":"2021","journal-title":"Cancer Res"},{"key":"pone.0318213.ref039","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1677\/erc.0.0060503","article-title":"Neuroendocrine cells in tumour growth of the prostate","volume":"6","author":"P. A. Abrahamsson","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"pone.0318213.ref040","first-page":"273","article-title":"Neuroendocrine differentiation of prostate cancer: a review","volume":"2","author":"V. Parimi","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"pone.0318213.ref041","doi-asserted-by":"crossref","first-page":"e0200472","DOI":"10.1371\/journal.pone.0200472","article-title":"The deregulation of miR-17\/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells","volume":"13","author":"J. T. Dankert","year":"2018","journal-title":"PLoS One"},{"key":"pone.0318213.ref042","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/cas.14224","article-title":"Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy","volume":"111","author":"Y. Otsuki","year":"2020","journal-title":"Cancer Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T18:37:05Z","timestamp":1738003025000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0318213"}},"subtitle":[],"editor":[{"given":"Ajay Pratap","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0318213","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]}}}